Literature DB >> 14689816

Intravenous drug preparation practices: a survey in a French university hospital.

Patrick Tilleul1, Bisserka Mons, Claude Schmitt, Jean-Marie Laporte, Dominique Begue.   

Abstract

OBJECTIVE: To describe current practices for i.v. drug admixture preparation, to identify potential improvements for the enhancement of patient safety.
DESIGN: A survey was conducted in a University hospital in Paris. Nurse practices were explored through the evaluation of five i.v. drug delivery systems: reconstituted freeze-dried drugs administered by syringe or i.v. bags, reconstituted drugs from vials administered by syringe or i.v. bags Ready to Use (RtU). PARTICIPANTS: i.v. drug preparation practices were documented by a representative sample of nurses in the following departments: intensive care, emergency, abdominal surgery, cardiology, infectious diseases, hepatology. MAIN OUTCOME MEASURES: Data were collected regarding: existence of written procedures for preparations, sources of information, labelling, methods of preparation and calculation of doses, nurse satisfaction regarding safety and ease of use of the different i.v. systems.
RESULTS: A total of 299 questionnaires were completed and 100 nurses from the chosen wards were surveyed. The study highlighted a lack of procedure (71-85%) and a lack of labelling (37%).
CONCLUSION: This survey highlighted areas for improvement in the preparation of i.v. drugs. It may contribute to raising awareness among nurses and physicians about the risks of medication errors. This survey also helped the pharmacy department in supporting the development of pharmaceutical procedures, the development of satellite pharmacy, the set up of training sessions for i.v. preparation and the switch toward ready to use packages when these are available.

Entities:  

Mesh:

Year:  2003        PMID: 14689816     DOI: 10.1023/b:phar.0000006522.84493.4e

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  8 in total

1.  Incidence and risk factors of preparation errors in a centralized cytotoxic preparation unit.

Authors:  S Limat; J P Drouhin; K Demesmay; E Tissot; M Jacquet; M C Woronoff-Lemsi
Journal:  Pharm World Sci       Date:  2001-06

2.  [Presentation of the study by the pharmacy of the Heidelberg Uniclinic. Medication errors with serious sequelae].

Authors:  Torsten Hoppe-Tichy; Simone Noe-Schwenn; Alexandra Wahlig; Katja Taxis
Journal:  Pflege Aktuell       Date:  2002-09

3.  Preventing medication errors in cancer chemotherapy.

Authors:  M R Cohen; R W Anderson; R M Attilio; L Green; R J Muller; J M Pruemer
Journal:  Am J Health Syst Pharm       Date:  1996-04-01       Impact factor: 2.637

4.  Observational study of accuracy in compounding i.v. admixtures at five hospitals.

Authors:  E A Flynn; R E Pearson; K N Barker
Journal:  Am J Health Syst Pharm       Date:  1997-04-15       Impact factor: 2.637

5.  Drug product characteristics that foster drug-use-system errors.

Authors:  M R Cohen
Journal:  Am J Health Syst Pharm       Date:  1995-02-15       Impact factor: 2.637

6.  Premixed intravenous admixtures: a positive development for hospital pharmacy.

Authors:  H E Lee
Journal:  Am J Hosp Pharm       Date:  1983-06

7.  Premixed intravenous admixtures: a critical challenge for hospital pharmacy.

Authors:  A J Loeb; D A Fishman; T R Kochis
Journal:  Am J Hosp Pharm       Date:  1983-06

8.  Medication errors at the administration stage in an intensive care unit.

Authors:  E Tissot; C Cornette; P Demoly; M Jacquet; F Barale; G Capellier
Journal:  Intensive Care Med       Date:  1999-04       Impact factor: 17.440

  8 in total
  2 in total

1.  Improving tenoxicam solubility and bioavailability by cosolvent system.

Authors:  Ming-Kung Yeh; Li-Chien Chang; Andy Hong-Jey Chiou
Journal:  AAPS PharmSciTech       Date:  2009-02-18       Impact factor: 3.246

2.  The use of prefilled adrenaline syringes improves cardiopulmonary resuscitation quality-high-fidelity simulator-based study.

Authors:  Radosław Zalewski; Mateusz Puślecki; Tomasz Kłosiewicz; Maciej Sip; Bartłomiej Perek
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.